“…This included seven studies [ 21 , 44 , 53 , 74 , 76 , 86 , 91 ] (21%) conducted during the sub-acute (≤ three months) stage (range 1.9–10.3 weeks, M = 3.86 weeks, SD = 3.23), while the remainder completed VR interventions during the chronic (> 3 months post-stroke) stage (range 17.2–427.8 weeks, M = 127.40 weeks, SD = 132.5). Seventeen studies [ 13 , 21 , 53 , 57 , 74 , 77 , 79 – 82 , 85 , 87 , 91 , 92 , 94 ] included both ischemic and hemorrhagic stroke patients, three included only ischemic stroke patients [ 78 , 86 , 93 ], and 11 did not report specific details about stroke type. Only three studies [ 21 , 74 ] reported data on stroke severity, two utilizing the National Institutes of Health Stroke Scale (NIHSS) and one study [ 86 ] used the Canadian Neurological Scale of Stroke Severity.…”